nadunolimab,pembrolizumab
cantargia,merck
['keytruda', 'sclc', 'nsclc', 'nadunolimab', 'cantargia']
 will you discuss cantargia s ph2 in nsclc? they have an abstract at #asco22 with their il1rap antibody nadunolimab in combination with chemotherapy that looks really promising, especially in non-squamos and patients previously treated with keytruda orr 88%
Småsparare på börsen sen 2015 Cantargia ägare sedan 2016